Tenderwize
Back to tender search

Open house discount agreements for Secukinumab

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Feb 28, 2027 · 191 days left·Open·Supplies
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Secukinumab, ATC L04AC10

40/100

Opportunity Score

Needs reviewLow complexity
SuppliesOpen
Why this score?

Opportunity

40 / 100

Complexity

20 / 100

Risk factors

The buyer reserves the right to replace open-house contracts with exclusive contracts from separate tenders, which woul...

No estimated value or volume guarantees; actual uptake depends on prescribing behavior and number of participants.

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Apr 2027
  • Supply of Secukinumab (ATC L04AC10) pharmaceutical products
  • Enter into non-exclusive discount agreements with AOK Rheinland-Pfalz/Saarland
Show full summary

Open House non-exclusive discount agreement for Secukinumab (ATC L04AC10) by AOK Rheinland-Pfalz/Saarland. The procedure is open for all interested pharmaceutical companies to enter into discount contracts under uniform conditions. The contract term is max 24 months starting 01.05.2025, with rolling entry on the first of each month. The notice explicitly states it is not a public procurement under EU directive 2014/24/EU.

Risks

The buyer reserves the right to replace open-house contracts with exclusive contracts from separate tenders, which woul...

No estimated value or volume guarantees; actual uptake depends on prescribing behavior and number of participants.

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Only authorized and marketable drugs in Germany may be supplied
  • For drugs not yet in Lauer-Taxe: provide AMIce database extract with proof of authorization and marketability

Administrative

  • Submission of signed contract documents

Requirements may be incomplete.

Award Criteria

Lot 1

No award criteria specified; this is an open-house model with no selection.

Buyer

Lots (1)

LOT-0001

Open house discount agreements for Secukinumab

Non-exclusive discount contracts for Secukinumab (ATC L04AC10). All interested pharmaceutical companies can participate under uniform terms. Contracts are non-exclusive and may be replaced by exclusive contracts from separate tenders. Maximum duration 24 months from earliest start date (01.05.2025).

SuppliesEU fundedElectronic submission

Location

Eisenberg, Germany

Duration

Apr 2025 - Apr 2027

Category

Pharmaceutical products

Award Criteria

No award criteria specified; this is an open-house model with no selection.

Deadline

Deadline Feb 28, 2027

Procurement Details

Publication date
12 Mar 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
162068-2025

Documents (1)

Similar tenders